Close
Achema middle east
swop processing & packaging

Amgen To Participate In The 2016 World Medical Innovation Forum™ On Cancer

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Matica Bio Gets a U.S. Biotech Commercial Manufacturing Deal

Matica Biotechnology, Inc., which happens to be a leading...

The Latest Breakthroughs in Dental Treatments

Dental care has moved well beyond fillings and routine...

How Can Digital Tools Improve Medication Adherence in Patients?

Medication adherence has long been one of healthcare’s toughest...

Russia, Vietnam Collaborate on Biopharma Technology Transfer

Russia and Vietnam have gone on to officially formalize...

Amgen announced plans to participate in the World Medical Innovation Forum™ on cancer held April 25-27, 2016, in Boston. The World Medical Innovation Forum is a global gathering of senior corporate, investor and academic leaders. The forum was established to respond to the intensifying transformation of healthcare and its impact on innovation. This is the second year Amgen has participated in this event as a sponsor.

Three senior leaders from Amgen are scheduled to speak:

Robert A. Bradway, chairman and chief executive officer, will participate in a fireside chat with Caroline Chen, a biotechnology and healthcare reporter at Bloomberg. The discussion will highlight Amgen’s strategic focus in oncology/hematology, its approach to innovation, and its investment in immuno-oncology and combination therapies. This event is scheduled for 10:25 a.m. ET on Tuesday, April 26.

Sean E. Harper, M.D., executive vice president of Research and Development, will participate on the “Creating a Disruptive Cancer Pipeline” panel moderated by Robert Tepper, M.D., a partner at Third Rock Ventures and an adjunct professor at Harvard Medical School. The expert panel members will discuss the considerations in cancer pipeline development, the tradeoffs and what it takes to maintain success over time. The panel is scheduled for 2:20 p.m. ET on Monday, April 25.

Sean E. Harper, M.D., executive vice president of Research and Development, will participate on the “Creating a Disruptive Cancer Pipeline” panel moderated by Robert Tepper, M.D., a partner at Third Rock Ventures and an adjunct professor at Harvard Medical School. The expert panel members will discuss the considerations in cancer pipeline development, the tradeoffs and what it takes to maintain success over time. The panel is scheduled for 2:20 p.m. ET on Monday, April 25.

Latest stories

Related stories

Matica Bio Gets a U.S. Biotech Commercial Manufacturing Deal

Matica Biotechnology, Inc., which happens to be a leading...

The Latest Breakthroughs in Dental Treatments

Dental care has moved well beyond fillings and routine...

How Can Digital Tools Improve Medication Adherence in Patients?

Medication adherence has long been one of healthcare’s toughest...

Russia, Vietnam Collaborate on Biopharma Technology Transfer

Russia and Vietnam have gone on to officially formalize...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »